|
|
|
11.06.25 - 06:15
|
Research: BofAS Elevates TPs for ZAI LAB/ TIGERMED to HKD29.61/ HKD40.1 (AAStocks)
|
|
|
BofA Securities has released a report on Chinese pharma stocks, among them ZAI LAB (09688.HK) (ZLAB.US) announced last Monday (2nd) updated data from its Phase 1a/1b clinical trial of ZL-1310 for patients with extensive-stage small cell lung cancer.In second-line treatment, the unconfirmed objective response rate across all dose......
|
|
|
10.06.25 - 23:45
|
XFRA: DIVIDEND/INTEREST INFORMATION - 12.06.2025 - EQUBF_01 (XETRA)
|
|
|
Das Instrument 5HZ1 CNE1000040M1 HANGZHOU TIGERMED CO. H 1 EQUITY wird cum Dividende/Zinsen gehandelt am 11.06.2025 und ex Dividende/Zinsen am 12.06.2025
The instrument 5HZ1 CNE1000040M1 HANGZHOU TIGERMED CO. H 1 EQUITY has its pre-dividend/interest day on 11.06.2025 and its ex-dividend/interest day on 12.06.2025...
|
|
|
|
|
|
|
|
|
27.03.25 - 11:51
|
Tigermed Reports Full Year 2024 Results (PR Newswire)
|
|
|
HANGZHOU, China, March 27, 2025 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced......
|
|
|
|
|
28.08.24 - 12:27
|
Tigermed Reports 2024 Interim Results (PR Newswire)
|
|
|
HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced......
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
